by: JonChristopher Collins
The issues that have been reported with the Johnson & Johnson Vaccine has caused Health Officials in both Arkansas and Missouri to take action.
While federal authorities are investigating concerns about the both states have followed the action of other states in putting the use of company’s vaccine on hold.
Although, Johnson & Johnson’s vaccine is not in use for the state’s clinics, the Arkansas Department of Health said clinics providing Pfizer or Moderna vaccines will proceed.
Johnson & Johnson’s COVID-19 vaccine is not being dispensed but being put on pause in Missouri as well. This comes soon after federal health authorities make the recommendation.
The state’s action follows a revelation from the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC). NBC News reports that six women “between the ages of 18 and 48 developed blood clots after receiving the Johnson & Johnson vaccine.” The FDA said one person has died while another is in critical condition.
“We anticipate having more information shortly to make further decisions about overall vaccine distribution in light of this new development and will continue to update citizens who have been vaccinated with the J&J vaccine after the advisory committee meets at the federal level tomorrow,” Director of the Missouri Department of Health and Senior Services Dr. Randall Williams said.
Williams said halting the administration of the vaccine is being done out of an abundance of caution in addition to following federal guidelines.
OzarksFirst reported that anyone who has “received the J&J vaccine who develop a severe headache, abdominal pain, leg pain, or shortness of breath” three weeks after being vaccinated should make contact with their health care provider. Patients with other clinical questions should contact their health care provider or call the COVID-19 hotline at 877-435-8411.”